Northeast
New York
New York tends to align closely with conservative compliance interpretations for sterile and specialty compounding.
Legal context
Pharmacies often demand a clearer FDA basis for compounding before they will dispense peptides into the state.
What this means
PCAC review can help, but most pharmacies still wait for formal federal follow-through.
Providers should plan around longer sourcing delays for specialty peptides.
Established FDA-approved options retain the strongest access path.